MSI-1436
CAS No. 186139-09-3
MSI-1436( Trodusquemine | Aminosterol-1436 | MSI1436 )
Catalog No. M12875 CAS No. 186139-09-3
An non-competitive, allosteric inhibitor of PTP1B with Ki of 0.6 uM for PTP1B1-405; antagonizes HER2 signaling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 7380 | Get Quote |
|
| 50MG | 23760 | Get Quote |
|
| 100MG | 37620 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMSI-1436
-
NoteResearch use only, not for human use.
-
Brief DescriptionAn non-competitive, allosteric inhibitor of PTP1B with Ki of 0.6 uM for PTP1B1-405; antagonizes HER2 signaling.
-
DescriptionAn non-competitive, allosteric inhibitor of PTP1B with Ki of 0.6 uM for PTP1B1-405; antagonizes HER2 signaling, inhibits tumorigenesis in xenografts and abrogates metastasis in the NDL2 mouse model of breast cancer. Breast Cancer Phase 1 Clinical
-
In VitroIn HepG2, MSI-1436 (10 μM, 30 min) alone has no effect on phosphorylation of IRβ, but in conjunction with 100 nM insulin, MSI-1436 increases p-IRβ 18-fold over untreated cells and by approximately threefold over cells treated with insulin alone. MSI-1436's inhibition of TCPTP is approximately two logs less than the effect on PTP1B activity, with a resulting IC50 value of 224 μM. MSI-1436 (Trodusquemine, 10 μM) restores ERK phosphorylation in response to mGluR1/5 agonist DHPG in F11 neuronal cells. MSI-1436 (10 uM) rescues DHPG-induced holding currents and restores DSI in LMO4KO BLA neurons. MSI-1436 (0.1-100 μM) blocks PTP1B activity, has insulin-mimetic effects in cultured neuronal cells.
-
In VivoMSI-1436 (10 mg/kg, i.p.) causes obesity-dependent body weight, reduces total body fat content and adipocyte size and lipid content of white adipose tissue of mice. MSI-1436 treatment significantly reduces plasma insulin levels. MSI-1436 (10 mg/kg, i.p.) increases phosphorylation of STAT-3 2.7-fold and, in conjunction with 100 U/kg insulin, p-IRβ increases threefold over insulin alone-treated rats. MSI-1436 (Trodusquemine) exhibits anxiolytic effect through a restoration of endocannabinoid (eCB) signaling within the amygdala. MSI-1436 (5 mg/kg, i.p.) has an anti-diabetic effect on diabetic mice, and is sufficient to suppress food intake and cause weight loss in CD1 mice.
-
SynonymsTrodusquemine | Aminosterol-1436 | MSI1436
-
PathwayMetabolic Enzyme/Protease
-
TargetProtein Phosphatase/PTP
-
RecptorProtein Phosphatase/PTP
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number186139-09-3
-
Formula Weight685.0564
-
Molecular FormulaC37H72N4O5S
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCC(C)C(CCC(C)C1CCC2C1(CCC3C2C(CC4C3(CCC(C4)NCCCNCCCCNCCCN)C)O)C)OS(=O)(=O)O
-
Chemical NameCholestane-7,24-diol, 3-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-, 24-(hydrogen sulfate), (3β,5α,7α,24R)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Krishnan N, et al. Nat Chem Biol. 2014 Jul;10(7):558-66.
2. Qin Z, et al. Biochem Biophys Res Commun. 2015 Feb 27;458(1):21-7.
molnova catalog
related products
-
Guanabenz
Guanabenz (WY 8678) is an α2 adrenergic receptor agonist that is used as an antihypertensive agent.
-
AQX 1125
AQX 1125 (Rosiptor) is a specific, orally bioavailable SHIP1 activator.
-
JTT-551 sodium
JTT-551 sodium (JTT551, JTT 551) is a novel potent, selective inhibitor of protein tyrosine phosphatase 1B (PTP1B) with Ki of 0.22 uM.
Cart
sales@molnova.com